🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Just out in⁦⁩ ⁦⁦Blood Cancer Discovery⁩ ⁦.⁩ #mmsm aacrjournals.org/bloodcancerdis…

At #AACRbcd24,Irene Ghobrial shares experiences in early screening for #myeloma precursors-- lots more to learn in predicting prog, interaction w/ genetics & TME. Out NOW in Blood Cancer Discovery, Irene leads discussion on MGUS/SMM clinical trials to answer those Qs: bit.ly/49KVrS4

.Iannis Aifantis presents awesome work at #AACRbcd24 discussing the regulation of T cell interactions in #myeloid maligs. Read his recent review in Blood Cancer Discovery on the role of inflammation in myeloid disease: doi.org/10.1158/2643-3… #leusm #AML #inflammation

Nicole Gormley (FDA Oncology) shares regulatory perspective on #hemonc trial design at #AACRbcd24: defining biomarkers, surrogate endpoints. Read her NEW perspective out now w/ Irene Ghobrial on these considerations for #myeloma trials: aacrjournals.org/bloodcancerdis…

.Bruno Paiva at #AACRbcd24 on the clinical importance & promise of high-sensitivity MRD & CTC detection & kinetics in #myeloma, for risk strat, Tx guidance, resistance mech. Read his recent Blood Cancer Discovery article demonstrating this for Ide-cel response: aacrjournals.org/bloodcancerdis…

We are grateful to the entire Blood Cancer Discovery team for developing this meeting to showcase cutting-edge preclinical and clinical findings in the fields of cancer genomics and epigenetics, precursor conditions, tumor microenvironment, immunotherapy, and precision medicine. #AACRbcd24

Wrapping up #AACRbcd24, Ben Ebert Dana-Farber takes us through his lab's work screening for disease-associated TFs susceptible to Ub-ligase degradation. Check out his work in Blood Cancer Discovery characterizing one such interaction, ZMYM2 degraded by avadomide+CRBN: aacrjournals.org/bloodcancerdis…

Hanging up my Blood Cancer Discovery editor hat. THANK YOU to all authors who trusted me/us w/ your work & put faith in a new journal. Sci pub'ing may have flaws but there isn't a more dedicated team than Tanya Bondar et al giving each article deserved consideration. Excited for its future!

Congratulations to Owen Witte for receiving this year's AACR Award for Outstanding Achievement in Blood Cancer Research at #AACR24! Dr. Witte sat down with us for a Q&A on his storied history in translational research, out NOW: bit.ly/4apQuOI

Very proud to have helped compile this AACR Publications Collection on #disparities in cancer. So much excellent work being done to understand what drives differences in disease biology, access to care, and response to therapy. #ASCO24